Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Nicotine binding to brain receptors requires a strong cation–π interaction


Nicotine addiction begins with high-affinity binding of nicotine to acetylcholine (ACh) receptors in the brain. The end result is over 4,000,000 smoking-related deaths annually worldwide and the largest source of preventable mortality in developed countries. Stress reduction, pleasure, improved cognition and other central nervous system effects are strongly associated with smoking. However, if nicotine activated ACh receptors found in muscle as potently as it does brain ACh receptors, smoking would cause intolerable and perhaps fatal muscle contractions. Despite extensive pharmacological, functional and structural studies of ACh receptors, the basis for the differential action of nicotine on brain compared with muscle ACh receptors has not been determined. Here we show that at the α4β2 brain receptors thought to underlie nicotine addiction, the high affinity for nicotine is the result of a strong cation–π interaction to a specific aromatic amino acid of the receptor, TrpB. In contrast, the low affinity for nicotine at the muscle-type ACh receptor is largely due to the fact that this key interaction is absent, even though the immediate binding site residues, including the key amino acid TrpB, are identical in the brain and muscle receptors. At the same time a hydrogen bond from nicotine to the backbone carbonyl of TrpB is enhanced in the neuronal receptor relative to the muscle type. A point mutation near TrpB that differentiates α4β2 and muscle-type receptors seems to influence the shape of the binding site, allowing nicotine to interact more strongly with TrpB in the neuronal receptor. ACh receptors are established therapeutic targets for Alzheimer’s disease, schizophrenia, Parkinson’s disease, smoking cessation, pain, attention-deficit hyperactivity disorder, epilepsy, autism and depression1. Along with solving a chemical mystery in nicotine addiction, our results provide guidance for efforts to develop drugs that target specific types of nicotinic receptors.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: The binding site of AChBP, thought to resemble that of nAChRs.
Figure 2: Agonists and unnatural amino acids considered here.
Figure 3: Nonsense suppression in the α4β2 receptor.
Figure 4: Fluorination plots.
Figure 5: Single-channel recordings from wild-type α4β2 (conventional expression) and the F 3 -Trp mutant (nonsense suppression) at site B, with nicotine applied at EC 50 values (0.080 and 1.2 μM, respectively).


  1. Romanelli, M. N. et al. Central nicotinic receptors: structure, function, ligands, and therapeutic potential. ChemMedChem 2, 746–767 (2007)

    CAS  Article  Google Scholar 

  2. Corringer, P. J., Le Novere, N. & Changeux, J. P. Nicotinic receptors at the amino acid level. Annu. Rev. Pharmacol. Toxicol. 40, 431–458 (2000)

    CAS  Article  Google Scholar 

  3. Coe, J. W. et al. Varenicline: An α4β2 nicotinic receptor partial agonist for smoking cessation. J. Med. Chem. 48, 3474–3477 (2005)

    CAS  Article  Google Scholar 

  4. Gotti, C., Zoli, M. & Clementi, F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol. Sci. 27, 482–491 (2006)

    CAS  Article  Google Scholar 

  5. Mansvelder, H. D., Keath, J. R. & McGehee, D. S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33, 905–919 (2002)

    CAS  Article  Google Scholar 

  6. Nashmi, R. et al. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J. Neurosci. 27, 8202–8218 (2007)

    CAS  Article  Google Scholar 

  7. Tapper, A. R. et al. Nicotine activation of α4* receptors: sufficient for reward, tolerance, and sensitization. Science 306, 1029–1032 (2004)

    ADS  CAS  Article  Google Scholar 

  8. Kuryatov, A., Luo, J., Cooper, J. & Lindstrom, J. Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors. Mol. Pharm. 68, 1839–1851 (2005)

    CAS  Google Scholar 

  9. Zhong, W. et al. From ab initio quantum mechanics to molecular neurobiology: A cation-π binding site in the nicotinic receptor. Proc. Natl Acad. Sci. USA 95, 12088–12093 (1998)

    ADS  CAS  Article  Google Scholar 

  10. Brejc, K. et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411, 269–276 (2001)

    ADS  CAS  Article  Google Scholar 

  11. Sixma, T. K. & Smit, A. B. Acetylcholine binding protein (AChBP): a secreted glial protein that provides a high-resolution model for the extracellular domain of pentameric ligand-gated ion channels. Annu. Rev. Biophys. Biomol. Struct. 32, 311–334 (2003)

    CAS  Article  Google Scholar 

  12. Dougherty, D. A. Cys-loop neuroreceptors: structure to the rescue? Chem. Rev. 108, 1642–1653 (2008)

    CAS  Article  Google Scholar 

  13. Beene, D. L. et al. Cation-π interactions in ligand recognition by serotonergic (5–HT3A) and nicotinic acetylcholine receptors: The anomalous binding properties of nicotine. Biochemistry 41, 10262–10269 (2002)

    CAS  Article  Google Scholar 

  14. Dougherty, D. A. Physical organic chemistry on the brain. J. Org. Chem. 73, 3667–3673 (2008)

    CAS  Article  Google Scholar 

  15. Nowak, M. W. et al. In vivo incorporation of unnatural amino acids into ion channels in a Xenopus oocyte expression system. Methods Enzymol. 293, 504–529 (1998)

    CAS  Article  Google Scholar 

  16. Fonck, C. et al. Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive α4* nicotinic receptors. J. Neurosci. 25, 11396–11411 (2005)

    CAS  Article  Google Scholar 

  17. Filatov, G. N. & White, M. M. The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating. Mol. Pharmacol. 48, 379–384 (1995)

    CAS  PubMed  Google Scholar 

  18. Labarca, C. et al. Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors. Nature 376, 514–516 (1995)

    ADS  CAS  Article  Google Scholar 

  19. Kearney, P. et al. Dose-response relations for unnatural amino acids at the agonist binding site of the nicotinic acetylcholine receptor: Tests with novel side chains and with several agonists. Mol. Pharmacol. 50, 1401–1412 (1996)

    CAS  PubMed  Google Scholar 

  20. Moroni, M., Zwart, R., Sher, E., Cassels, B. K. & Bermudez, I. α4β2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol. Pharmacol. 70, 755–768 (2006)

    CAS  Article  Google Scholar 

  21. Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y. & Lindstrom, J. Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol. Pharmacol. 63, 332–341 (2003)

    CAS  Article  Google Scholar 

  22. Celie, P. H. et al. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41, 907–914 (2004)

    CAS  Article  Google Scholar 

  23. Hansen, S. B. et al. Structures of aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J. 24, 3635–3646 (2005)

    CAS  Article  Google Scholar 

  24. Talley, T. T. et al. Spectroscopic analysis of benzylidene anabaseine complexes with acetylcholine binding proteins as models for ligand-nicotinic receptor interactions. Biochemistry 45, 8894–8902 (2006)

    CAS  Article  Google Scholar 

  25. Cashin, A. L., Petersson, E. J., Lester, H. A. & Dougherty, D. A. Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor. J. Am. Chem. Soc. 127, 350–356 (2005)

    CAS  Article  Google Scholar 

  26. Deechongkit, S. et al. Context-dependent contributions of backbone hydrogen bonding to β-sheet folding energetics. Nature 430, 101–105 (2004)

    ADS  CAS  Article  Google Scholar 

  27. England, P. M., Zhang, Y., Dougherty, D. A. & Lester, H. A. Backbone mutations in transmembrane domains of a ligand-gated ion channel: implications for the mechanism of gating. Cell 96, 89–98 (1999)

    CAS  Article  Google Scholar 

  28. Koh, J. T., Cornish, V. W. & Schultz, P. G. An experimental approach to evaluating the role of backbone interactions in proteins using unnatural amino acid mutagenesis. Biochemistry 36, 11314–11322 (1997)

    CAS  Article  Google Scholar 

  29. Grutter, T. et al. An H-bond between two residues from different loops of the acetylcholine binding site contributes to the activation mechanism of nicotinic receptors. EMBO J. 22, 1990–2003 (2003)

    CAS  Article  Google Scholar 

  30. Sine, S. M. et al. Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 15, 229–239 (1995)

    CAS  Article  Google Scholar 

  31. McManus, O. B., Blatz, A. L. & Magleby, K. L. Sampling, log binning, fitting, and plotting durations of open-and-shut intervals from single channels and the effects of noise. Pflugers Archiv-Eur. J. Physiol. 410, 530–553 (1987)

    CAS  Article  Google Scholar 

Download references


We thank B. N. Cohen for advice on single-channel recording and analysis. This work was supported by the NIH (NS 34407; NS 11756) and the California Tobacco-Related Disease Research Program of the University of California, grant number 16RT-0160. J.A.P.S. was partially supported by an NRSA training grant.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Dennis A. Dougherty.

Supplementary information

Supplementary Information

This file contains Supplementary Figures 1-3 with Legends, Supplementary Table 1, a Supplementary Discussion and Supplementary References. (PDF 995 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Xiu, X., Puskar, N., Shanata, J. et al. Nicotine binding to brain receptors requires a strong cation–π interaction. Nature 458, 534–537 (2009).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing